This brand name is authorized in Austria
The drug SABANLEVA contains one active pharmaceutical ingredient (API):
|
1
Levetiracetam
UNII 44YRR34555 - LEVETIRACETAM
|
|
Levetiracetam, is a pyrrolidone derivative, chemically unrelated to existing antiepileptic active substances. Levetiracetam induces seizure protection in a broad range of animal models of partial and primary generalised seizures without having a pro-convulsant effect. The primary metabolite is inactive. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N03AX14 | Levetiracetam | N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
